Biotechnology Stocks: The Market’s Most Dangerous and Most Attractive Arena
Biotechnology stocks are among the most volatile assets in the market — but they are also where some of the biggest wealth stories are born. One FDA decision can create billions in value, while a single failed clinical trial can wipe a company out overnight....
24 January, 2026